Selective Toxicity of Bryodin and Momordin Immunotoxins
Author Information
Author(s): F. Stirpel, E.J. Wawrzynczak, A.N.F. Brown, R.E. Knyba, G.J. Watson, L. Barbieri, P.E. Thorpe
Primary Institution: Universita degli Studi di Bologna and Imperial Cancer Research Fund
Hypothesis
Can immunotoxins made from bryodin and momordin effectively target and kill Thy 1.1-expressing lymphoma cells?
Conclusion
Both bryodin and momordin immunotoxins were found to be selectively toxic to Thy 1.1-expressing lymphoma cells, with bryodin being significantly more effective.
Supporting Evidence
- Immunotoxins made with bryodin were more toxic than those made with momordin.
- Both immunotoxins were specifically cytotoxic to Thy 1.1-expressing cells.
- Neither immunotoxin affected Thy 1.1-negative cells.
Takeaway
This study shows that two plant proteins can be used to create targeted treatments for certain cancer cells, making them sick without hurting other cells.
Methodology
Immunotoxins were prepared by linking ribosome-inactivating proteins to a monoclonal antibody and tested for cytotoxic effects on specific lymphoma cell lines.
Limitations
The study primarily focused on in vitro experiments, which may not fully represent in vivo efficacy.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website